» Articles » PMID: 19933665

Percutaneous CT-guided Radiofrequency Ablation of Renal Cell Carcinoma: Efficacy of Organ Displacement by Injection of 5% Dextrose in Water into the Retroperitoneum

Overview
Specialties Oncology
Radiology
Date 2009 Nov 26
PMID 19933665
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this study was to evaluate the effectiveness of CT-guided injection of 5% dextrose in water solution (D5W) into the retroperitoneum to displace organs adjacent to renal cell carcinoma.

Materials And Methods: An interventional radiology database was searched to identify the cases of patients who underwent CT-guided percutaneous radiofrequency ablation of biopsy-proven renal cell carcinoma in which D5W was injected into the retroperitoneal space to displace structures away from the targeted renal tumor. The number of organs displaced and the distance between the renal tumor and adjacent organs before and after displacement with D5W were assessed.

Results: The cases of 135 patients with 139 biopsy-proven renal cell carcinomas who underwent 154 percutaneous CT-guided radiofrequency ablation procedures were found in the search. Thirty-one patients with 33 renal cell carcinomas underwent 36 ablation procedures after injection of D5W into the retroperitoneal space. Fifty-five organs were displaced away from renal cell carcinoma with this technique. The average distance between adjacent structures and renal cell carcinomas before displacement was 0.36 cm (range, 0.1-1.0 cm). The average distance between structures and adjacent renal cell carcinomas after displacement was 1.94 cm (range, 1.1-4.3 cm) (p < 0.0001). The average volume of D5W used to achieve organ displacement was 273.5 mL. No complications were associated with this technique.

Conclusion: CT-guided injection of D5W into the retroperitoneum is an effective method for displacing vital structures away from renal cell carcinoma.

Citing Articles

Temporary Organ Displacement to Escalate Radiation Dose to Retroperitoneal Tumors and Decrease Toxicity to Organs at Risk.

Maybody M, Soliman M, Yamada Y, Tahour D, Hsu M, Moskowitz C J Vasc Interv Radiol. 2020; 31(10):1578-1586.

PMID: 32861570 PMC: 7541436. DOI: 10.1016/j.jvir.2020.01.011.


Role of Endoscopic Ultrasound-guided Fine-needle Aspiration in Adrenal Lesions: Analysis of 32 Patients.

Gupta R, Majumdar K, Saran R, Srivastava S, Sakhuja P, Batra V J Cytol. 2018; 35(2):83-89.

PMID: 29643654 PMC: 5885609. DOI: 10.4103/JOC.JOC_241_16.


Endoscopic ultrasound-guided fine-needle aspiration of enlarged adrenals in patients with pyrexia of unknown origin: A single-center experience of 52 cases.

Bansal R, Choudhary N, Patle S, Agarwal A, Kaur G, Sarin H Indian J Gastroenterol. 2018; 37(2):108-112.

PMID: 29594708 DOI: 10.1007/s12664-018-0825-1.


Tips and tricks for a safe and effective image-guided percutaneous renal tumour ablation.

Mauri G, Nicosia L, Varano G, Bonomo G, Della Vigna P, Monfardini L Insights Imaging. 2017; 8(3):357-363.

PMID: 28500486 PMC: 5438321. DOI: 10.1007/s13244-017-0555-4.


Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis of adrenal lesions.

Patil R, Ona M, Papafragkakis C, Duddempudi S, Anand S, Jamil L Ann Gastroenterol. 2016; 29(3):307-11.

PMID: 27366030 PMC: 4923815. DOI: 10.20524/aog.2016.0047.